Your browser doesn't support javascript.
loading
Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.
van den Hoek, Anita M; Verschuren, Lars; Caspers, Martien P M; Worms, Nicole; Menke, Aswin L; Princen, Hans M G.
Afiliação
  • van den Hoek AM; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, The Netherlands. a.vandenhoek@tno.nl.
  • Verschuren L; Department of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), Zeist, The Netherlands.
  • Caspers MPM; Department of Microbiology and Systems Biology, The Netherlands Organization for Applied Scientific Research (TNO), Zeist, The Netherlands.
  • Worms N; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, The Netherlands.
  • Menke AL; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, The Netherlands.
  • Princen HMG; Department of Metabolic Health Research, The Netherlands Organization for Applied Scientific Research (TNO), Leiden, The Netherlands.
Sci Rep ; 11(1): 5050, 2021 03 03.
Article em En | MEDLINE | ID: mdl-33658534

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propionatos / Síndrome Metabólica / Chalconas / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática / Obesidade Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propionatos / Síndrome Metabólica / Chalconas / Hepatopatia Gordurosa não Alcoólica / Cirrose Hepática / Obesidade Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article